DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Thursday reported a loss of $17.8 million in its second quarter.
The Durham, North Carolina-based company said it had a loss of 21 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The biopharmaceutical company posted revenue of $391,000 in the period.
Chimerix shares have climbed 34% since the beginning of the year. The stock has risen 94% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News